China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
China’s National Healthcare Security Administration (NHSA) has released its 2024 “Healthcare Security Development Statistical Bulletin.”...
BMI
China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation
The Chinese government has released a set of opinions detailing the establishment of a new...
In-Depth Analysis of NHSA’s DRG/DIP Payment Reforms: A Path to Streamlined Healthcare Management
Comprehensive Overhaul of Payment SystemsThe National Healthcare Security Administration (NHSA) has unveiled a series of...
NHSA Regulates DRG/DIP Payment Methods Under ‘1+3+N’ System
The National Healthcare Security Administration (NHSA) has released a set of regulations aimed at improving...
China’s NHSA and MoF Push for DRG/DIP Payment Reforms by 2025
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly released...
NHSA Targets Low-Volume Drugs in National Reimbursement List
The National Healthcare Security Administration (NHSA) in China has released a list of 131 drugs...
NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification to promote the real-time settlement...
NHSA Launches Nationwide Self-Inspection Campaign on Medical Insurance Fund Usage
China’s National Healthcare Security Administration (NHSA) released a notification last weekend, mandating designated medical institutions...
China’s NHSA Implements New Regulations for Medical Insurance Payment Qualifications
China’s National Healthcare Security Administration (NHSA) has released the “Regulations on the Management of Medical...
Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
A national conference on healthcare security was recently held in Beijing, reviewing the achievements of...
Beijing Expands Medical Insurance Sharing to Near Relatives with New Policy
The Beijing Municipal Medical Insurance Bureau has released a notification that significantly expands the scope...
National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate
The National Reimbursement Drug List (NRDL) negotiations for the year have concluded, with less than...
Hunan Province Includes Fertility Treatments in Medical Insurance Coverage from October 2024
The Hunan Healthcare Security Administration has issued a notification to include specific assisted reproductive medical...
AstraZeneca Faces Investigation in China Over Data Privacy and Unapproved Drugs
AstraZeneca (NASDAQ: AZN), a leading UK pharmaceutical company, is reportedly under the spotlight in Shenzhen,...
China Unveils 2024 Plan to Combat Fraud in Medical Insurance Funds
The National Healthcare Security Administration (NHSA) of China, in conjunction with the Supreme People’s Court,...
Chinese Authorities Launch Special Plan to Rectify Medical Insurance Fraud and Non-Compliance
The National Healthcare Security Administration (NHSA) of China, in collaboration with the Supreme People’s Court,...
Hebei Province Proposes Measures for ‘Internet+’ Medical Services and Insurance Management
The Hebei provincial Healthcare Security Administration (HSA) bureau has released a draft set of Measures...
Hunan Province Hospitals Commit to Implementing Nationally Negotiated Drugs in Policy Seminar
A policy seminar under the auspices of the Hunan Healthcare Security Administration bureau convened in...
China Regulators Chart Steady Path for ‘Huiminbao’ Medical Insurance Schemes
The China Banking and Insurance Regulatory Commission (CBIRC) and National Healthcare Security Administration (NHSA) have...
China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024
The National Healthcare Security Administration (NHSA) has issued a notification aimed at fostering inter-provincial price...